Nimotuzumab plus concurrent chemo-radiotherapy versus chemo-radiotherapy in unresectable locally advanced esophageal squamous cell carcinoma (ESCC): Interim analysis from a prospective, randomized-controlled, double-blinded, multicenter, and phase III clinical trial (NXCEL1311 Study).

被引:0
|
作者
Meng, Xue
Zheng, Anping
Wang, Jun
Wang, Jianhua
Li, Guang
Zhu, Jun
Ma, Hu
Zhu, Xiaodong
Shi, Anhui
Dai, Chunhua
Yan, Senxiang
Wang, Buhai
Qu, Zhongyu
Han, Chun
Sun, Xindong
Ye, Ming
Fan, Ruitai
Huerxidan, Ni Yazi
Wang, Xiaohong
Yu, Jinming
机构
[1] Shandong Canc Hosp & Inst, Dept Radiat Oncol, Jinan, Peoples R China
[2] Anyang Canc Hosp, Anyang, Peoples R China
[3] Hebei Med Univ, Hosp 4, Dept Radiat Oncol, Shijiazhuang, Peoples R China
[4] Zhengzhou Univ, Affiliated Canc Hosp, Henan Canc Hosp, Zhengzhou, Peoples R China
[5] China Med Univ, Hosp 1, Dept Radiat Oncol, Shenyang, Peoples R China
[6] Jiangsu Canc Hosp, Nanjing, Peoples R China
[7] Zunyi Med Univ, Affiliated Hosp 2, Zunyi, Guizhou, Peoples R China
[8] Guangxi Med Univ, Affiliated Tumor Hosp, Nanning, Guangxi, Peoples R China
[9] Beijing Canc Hosp, Beijing, Peoples R China
[10] Jiangsu Univ, Affiliated Hosp, Zhenjiang, Jiangsu, Peoples R China
[11] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Hangzhou, Peoples R China
[12] Northern Jiangsu Peoples Hosp, Yangzhou, Peoples R China
[13] Henan Prov Nanyang Cent Hosp, Nanyang, Peoples R China
[14] Hebei Med Univ, Hosp 4, Shijiazhuang, Hebei, Peoples R China
[15] Shandong First Med Univ, Shandong Canc Hosp & Inst, Dept Radiat Oncol, Jinan, Peoples R China
[16] Shandong Acad Med Sci, Jinan, Peoples R China
[17] Shanghai Jiao Tong Univ, Sch Med, Renji Hosp, Shanghai, Peoples R China
[18] Zhengzhou Univ, Affiliated Hosp 1, Zhengzhou, Peoples R China
[19] Xinjiang Med Univ, Affiliated Hosp 1, Urumqi, Peoples R China
[20] Henan Univ Sci & Technol, Affiliated Hosp 1, Luoyang, Peoples R China
[21] Shandong Canc Hosp & Inst, Jinan, Peoples R China
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
4016
引用
收藏
页数:1
相关论文
共 31 条